Financials
- Market Capitalization 1.8 B
- Employee 298
- Founded 2005
- CEO N/A
- Website www.syndax.com
- Headquarter Delaware, United States
- FIGI BBG000R33JY1
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-6.39
Fiyat/satışlar oranı
10.56
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2075 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.11 USD | -0.61% | +3.64% | +21.73% | -4.45% | 1.84 B USD | ||
| 2079 | INBX Inhibrx Biosciences, Inc. - Common Stock | 123.93 USD | -1.12% | +23.00% | +55.05% | +53.80% | 1.82 B USD | ||
| 2086 | FTRE Fortrea Holdings Inc. - Common Stock | 18.86 USD | +1.78% | +3.06% | -3.73% | +93.24% | 1.79 B USD | ||
| 2097 | GHRS GH Research PLC - Ordinary Shares | 28.65 USD | -1.24% | -0.62% | +2.54% | +102.33% | 1.78 B USD |